This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Peter Francis Pankowicz
Introduction
Peter Francis Pankowicz is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of biomedical research, particularly in the development of innovative models for drug testing. His work focuses on creating chimeric non-human animals that can aid in understanding human liver functions.
Latest Patents
Pankowicz holds a patent for a "Human liver chimeric mouse with deficient P450 oxidoreductase." This patent describes a chimeric non-human animal that comprises human hepatocytes. The methods outlined in the patent detail how to prepare these chimeric animals and utilize them for screening and identifying metabolites for various drugs, especially small molecule drugs. This innovation is crucial for assessing how different substances may affect human liver functions and other bodily functions.
Career Highlights
Pankowicz is affiliated with the Baylor College of Medicine, where he conducts his research. His work has garnered attention for its potential to revolutionize drug testing and development processes. With a focus on enhancing the understanding of human biology through innovative animal models, he continues to push the boundaries of biomedical research.
Collaborations
Some of his notable coworkers include Karl-Dimiter Bissig and Maria De Las Mercedes Barzi Dieguez. Their collaborative efforts contribute to the advancement of research in the field of liver function and drug metabolism.
Conclusion
Peter Francis Pankowicz is a notable inventor whose work in creating chimeric non-human animals has the potential to significantly impact drug testing and development. His contributions to biomedical research are paving the way for more effective and safer pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
